Release Date: 17/11/11 14:23 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 44.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%